AEMD
Aethlon Medical·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 0
Stock Price Surged Significantly
Ample Liquidity
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About AEMD
Aethlon Medical, Inc.
A medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening infectious diseases
Healthcare Equipment and Supplies
03/10/1999
07/10/2015
NASDAQ Stock Exchange
9
03-31
Common stock
11555 Sorrento Valley Road, Suite 203 , San Diego, California 92121
--
Aethlon Medical, Inc., was incorporated in Nevada on March 10, 1999. The company is a medical device company focused on creating innovative devices that address the unmet medical needs of cancer, infectious diseases and other life-threatening diseases. At the heart of its development is the Aethlon ADAPT system, a medical device platform that combines single or multiple affinity drugs with advanced plasma membrane technology to create therapeutic filtration devices that selectively remove harmful particles from the entire circulatory system without losing essential blood components.
Earnings Call
Q1/2026
Estimate EPS-0.73
Actual EPS-0.85
Estimate Revenue--
Actual Revenue0
Aethlon Medical's 2026 Q1: Unraveling Contradictions in Oncology Focus, Trial Strategies, and Enrollment Challenges
Aug 13,2025 08:47
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
AEMD has released its 2026 Q2 earnings. EPS was reported at -3.74, versus the expected -1.7, missing expectations. The chart below visualizes how AEMD has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
